이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
에너지 및 환경 · 2015. 3. 12.1 분 읽기
SHINE Medical Technologies, Inc.; Notice of Hearing, Opportunity To Intervene, Order Imposing Procedures
로컬 자동 번역 · 원본 출처 언어
요약
The U.S. Nuclear Regulatory Commission (NRC) has received a construction permit application from SHINE Medical Technologies, Inc. (SHINE), for approval of a proposed medical radioisotope production facility for the production of molybdenum-99 (Mo-99) at a site located in Janesville, Wisconsin. The NRC is currently conducting a detailed technical review of the construction permit application. If the construction permit application is approved, the applicant would be authorized to construct its proposed medical radioisotope production facility in accordance with the provisions of the construction permit.
원본 출처 언어: Federal Register — Nuclear Regulatory Commission원문 발표 열기 →